REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

Launched by MASSACHUSETTS GENERAL HOSPITAL · Aug 15, 2023

Keywords

ClinConnect Summary

The REACH-Es trial is studying a new digital health tool designed to help Latino adults with type 2 diabetes stick to their medication schedules. This tool uses text messages to provide support and address specific challenges that Latino individuals face when taking their diabetes medications. Since Latino adults often have a harder time adhering to their medication, this study aims to see if this interactive approach can make a positive difference in their diabetes management and overall health.

To participate, individuals must be at least 18 years old, identify as Latino or Hispanic, and speak and read Spanish. They should also have type 2 diabetes, be taking at least one diabetes medication, and have a recent HbA1c level of 8.0% or higher, which indicates poor blood sugar control. Participants will need access to a mobile phone that can send and receive text messages. The study is currently recruiting participants, and if you join, you will receive support through text messages tailored to help you manage your medication better. This could be an important step in improving health outcomes for Latino adults with diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Type 2 diabetes mellitus
• • Have current or prior (since 2018) HbA1c ≥8.0%
• • Take at least one diabetes medication
• • Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years)
• • ≥18 yrs
• • Identify as Latino and/or Hispanic
• • Speak and read in Spanish as preferred language
• • Willing and able to provide informed consent
• • Access to a mobile telephone with text messaging capability
• • Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study.
• Exclusion Criteria:
• • Auditory limitations and/or inability to communicate orally
• • Inability to receive, read, or send a text message (assessed by a trained research assistant)